Exact Sciences
EXAS
#1882
Rank
โ‚น743.49 B
Marketcap
โ‚น4,003
Share price
2.05%
Change (1 day)
-20.34%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Operating Margin for Exact Sciences (EXAS)

Operating Margin as of March 2025 (TTM): -37.55%

According to Exact Sciences's latest financial reports and stock price the company's current Operating Margin is -37.55%. At the end of 2024 the company had an Operating Margin of -37.56%.

Operating Margin history for Exact Sciences from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-37.56%365.36%
2023-8.07%-73.41%
2022-30.35%-36.34%
2021-47.68%-14.23%
2020-55.59%19.85%
2019-46.38%20.41%
2018-38.52%-10.58%
2017-43.08%-74.4%
2016-168.26%-57.95%
2015-400.14%-92.8%
2014-5,561.07%395.97%
2013-1,121.26%-11.36%
2012-1,264.99%83.89%
2011-687.92%218.95%
2010-215.68%10.94%
2009-194.41%-82.01%
2008-1,080.85%171.83%
2007-397.61%39.94%
2006-284.13%-19.54%
2005-353.13%-9.21%
2004-388.96%-60.87%
2003-994.07%-70.16%
2002-3,331.44%-92.77%
2001-46,049.02%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-14.74%-60.75%๐Ÿ‡บ๐Ÿ‡ธ USA
31.38%-183.58%๐Ÿ‡บ๐Ÿ‡ธ USA
5.77%-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-124.57% 231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
15.12%-140.27%๐Ÿ‡ซ๐Ÿ‡ท France

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.